Home › Melanoma › California › San Francisco
Studi clinici su Melanoma a San Francisco, CA
22 studi su Melanoma cercano partecipanti presso sedi a San Francisco e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
In reclutamentoFase 2
- UCSF Medical Center at Mission Bay ( Site 4044), San Francisco
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
In reclutamentoFase 3
- University of California San Francisco (UCSF), San Francisco
Intratumoral N17350 in Advanced Solid Tumors
In reclutamentoFase 1/2
- University of California, San Francisco, San Francisco
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
In reclutamentoFase 2
- Local Institution - 0096, San Francisco
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
In reclutamentoFase 1/2
- University of California-San Fransisco, San Francisco
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
In reclutamentoFase 1
- University of California San Francisco, San Francisco
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
In reclutamentoFase 1/2
- University of California San Francisco, San Francisco
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
In reclutamentoFase 1/2
- UCSF Medical Center-Mission Bay, San Francisco
Project: Every Child for Younger Patients With Cancer
In reclutamentoStudio osservazionale
- UCSF Medical Center-Mission Bay, San Francisco
Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma
In reclutamentoFase 2
- University of California, San Francisco, San Francisco
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
In reclutamentoFase 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Neoadjuvant Darovasertib in Primary Uveal Melanoma
In reclutamentoFase 3
- UCSF Wayne and Gladys Valley Center for Vision, San Francisco
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
In reclutamento
- Zuckerberg San Francisco General, San Francisco
- Kaiser Foundation Research Institute, San Francisco
- University of San Francisco, San Francisco
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
In reclutamentoFase 1/2
- University of California San Francisco (UCSF), San Francisco
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
In reclutamentoFase 2/3
- UCSF, San Francisco
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
In reclutamentoFase 1
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
In reclutamentoStudio osservazionale
- Kaiser Permanente-San Francisco, San Francisco
ACTengine® IMA203 Combined With mRNA-4203
In reclutamentoFase 1
- University of California San Francisco, San Francisco
Mirdametinib in Patients With Advanced NF1-mutant Melanoma
In reclutamentoFase 2
- California Pacific Medical Center - Sutter Health, San Francisco
Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma
In reclutamentoStudio osservazionale
- University of California, San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, San Francisco
A Study of IBI363 in Subjects with Advanced Solid Malignancies
In reclutamentoFase 2
- University of California, San Francisco (UCSF), San Francisco
Studi su Melanoma in altre città
- Houston, TX59 studi
- New York City, NY38 studi
- Los Angeles, CA34 studi
- Nashville, TN33 studi
- Pittsburgh, PA31 studi
- Boston, MA26 studi
- Philadelphia, PA23 studi
- Durham, NC21 studi
- Atlanta, GA21 studi
- St. Louis, MO21 studi
- Salt Lake City, UT21 studi
- Columbus, OH21 studi
Altri studi a San Francisco
- Cancro alla prostata45 studi
- Cancro al seno43 studi
- Cancro del polmone non a piccole cellule36 studi
- Cancro (tutti i tipi)35 studi
- Insufficienza cardiaca29 studi
- Cancro metastatico28 studi
- Cancro ai polmoni23 studi
- Cancro pancreatico20 studi
- Cancro ovarico19 studi
- Cancro colorettale18 studi
- Malattie cardiovascolari18 studi
- Glioblastoma17 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.